In a market environment that, up until recently, has been severely difficult for producers of chemical pharmaceutical products to operate in, three enterprising Serbian companies – Pharmanova, INNventa and Esensa - have found success by stepping up their offering in…
Nenad Djordjevic, managing director of Esensa, introduces the Belgrade company’s 200-strong portfolio of medical devices, food supplements, cosmetics and general use items; how it is now exporting its ‘made in…
Between 2010 and 2012 just one of the 139 new medicines to receive market authorisations globally was approved for reimbursement in Serbia, compared with 44 in Bulgaria and 27 in…
Nenad Djordjevic, managing director of Esensa, introduces the Belgrade company’s 200-strong portfolio of medical devices, food supplements, cosmetics and general use items; how it is now exporting its ‘made in…
Branislav Kotlarik, Ferring’s general manager for the Balkans – whose remit includes Hungary, Romania and Bulgaria as well as all of ex-Yugoslavia – gives his insights into managing such a diverse region; Ferring’s commitment to reproductive medicine; and the intricacies of gaining reimbursement for innovative products on the Serbian market. What are your responsibilities as Ferring’s Balkans manager and what…
Dragan Odzaklijevic, CEO of acb, the exclusive correspondent of leading global insurance broker Aon in Serbia, discusses the Serbian insurance market, which of acb’s services are most in demand for…
PharmaBoardroom today releases its new 42-page Healthcare & Life Sciences Review Serbia 2018. Situated on the edge of Europe and with a reputation scarred by the conflicts of the 1990s,…
PharmaBoardroom today releases its new 42-page Healthcare & Life Sciences Review Serbia 2018. Situated on the edge of Europe and with a reputation scarred by the conflicts of the 1990s,…
See our Cookie Privacy Policy Here